---
schema_version: "secwatch.filing_event.v1"
accession: "0001575872-26-000709"
form_type: "8-K"
ticker: "NUMD"
cik: "0001543637"
company_name: "Nu-Med Plus, Inc."
filed_at: "2026-10-20T12:56:16+00:00"
generated_at: "2026-10-20T13:00:03.490964+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Nu-Med Plus raises $450,000 selling 171,232 Series A Preferred at $2.628; conversion equals 3.42M common

## Summary
- Two accredited investors bought 171,232 shares of Series A Preferred at $2.628 per share for aggregate proceeds of $450,000 on Oct 19, 2026.
- Investors got piggy-back registration rights to include conversion shares in any resale registration statement the company files within two years.
- Full conversion of the investors' preferred would yield 3,424,640 common shares; a consultant's 50,000 preferred converts into 1,000,000 common shares.
- The company issued the consultant 50,000 Series A Preferred for services rendered and paid no sales commissions on any of the sales.
- Offering is best-efforts with no minimum, capped at 190,258 shares or $500,000, ending Oct 30, 2026 unless the board extends up to 90 days.

## SEC filing metadata
- accession: 0001575872-26-000709
- form_type: 8-K
- ticker: NUMD
- cik: 0001543637
- company_name: Nu-Med Plus, Inc.
- filed_at: 2026-10-20T12:56:16+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1543637/000157587226000709/0001575872-26-000709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1543637/000157587226000709/numd_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001575872-26-000709
- JSON: https://secwatch.observer/filing/0001575872-26-000709.json
- Plain text: https://secwatch.observer/filing/0001575872-26-000709.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.